Prescription drug · ANDA
Methocarbamol NDC 82461-723
Methocarbamol 750 mg/1 · Tablet, Film coated · Oral · Medcore LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 82461-723-90 | 82461072390 | 90 TABLET, FILM COATED in 1 BOTTLE (82461-723-90)Marketed from Jul 31, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methocarbamol
- Generic name (nonproprietary)
- methocarbamol
- Active ingredients
- Methocarbamol — 750 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Medcore LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 212623
- Marketing start
- Listing expires
- Other FDA classes
- Centrally-mediated Muscle Relaxation (Physiologic effect)
- Identifiers
- Product ID 82461-723_1745e58f-e6fb-43d8-a738-74a2cc80db48SPL ID 1745e58f-e6fb-43d8-a738-74a2cc80db48SPL set ID 1a6b7327-fd42-4de0-bd0d-2dd478502d52RxCUI 197943, 197944UNII 125OD7737XUPC 0382461723903, 0382461722906
- Pharmacologic class
- Muscle Relaxant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N482461072390followed by a unit qualifier and the quantityPackage 82461-0723-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Methocarbamol Tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 212623
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methocarbamol Tablets, USP, 750 mgmethocarbamol | Methocarbamol 750 mg/1 | Tablet, Film coatedOral | PD-Rx Pharmaceuticals, Inc. | 72789-521 |
| Methocarbamol Tablets, USP, 750 mgmethocarbamol | Methocarbamol 750 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-2488 |
| Methocarbamol Tablets, USP, 500 mgmethocarbamol | Methocarbamol 500 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-2487 |
| Methocarbamol | Methocarbamol 500 mg/1 | Tablet, Film coatedOral | Medcore LLC | 82461-722 |
| Methocarbamol Tablets, USP, 500 mgmethocarbamol | Methocarbamol 500 mg/1 | Tablet, Film coatedOral | Marlex Pharmaceuticals, Inc. | 10135-722 |
| Methocarbamol Tablets, USP, 750 mgmethocarbamol | Methocarbamol 750 mg/1 | Tablet, Film coatedOral | Marlex Pharmaceuticals, Inc. | 10135-723 |
| Methocarbamol Tablets, USP, 500 mgmethocarbamol | Methocarbamol 500 mg/1 | Tablet, Film coatedOral | PD-Rx Pharmaceuticals, Inc. | 72789-481 |
| Methocarbamol Tablets, USP, 500 mgmethocarbamol | Methocarbamol 500 mg/1 | Tablet, Film coatedOral | PD-Rx Pharmaceuticals, Inc. | 72789-499 |
| Methocarbamol Tablets, USP, 500 mgmethocarbamol | Methocarbamol 500 mg/1 | Tablet, Film coatedOral | Granulation Technology, Inc. | 63561-0173 |
| Methocarbamol Tablets, USP, 750 mgmethocarbamol | Methocarbamol 750 mg/1 | Tablet, Film coatedOral | Granulation Technology, Inc. | 63561-0174 |